1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups
(
- Contribution to journal › Article
- 2022
-
Mark
The Risk of Endometrial Malignancy and Other Endometrial Pathology in Women with Abnormal Uterine Bleeding : An Ultrasound-Based Model Development Study by the IETA Group
(
- Contribution to journal › Article
-
Mark
Risk assessment for endometrial cancer in women with abnormal vaginal bleeding : Results from the prospective IETA-1 cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Re : “Diagnostic Accuracies of the Ultrasound and Magnetic Resonance Imaging ADNEX Scoring Systems for Ovarian Adnexal Mass: Systematic Review and Meta-Analysis”
(
- Contribution to journal › Letter
- 2020
-
Mark
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively : multicentre cohort study
(
- Contribution to journal › Article
- 2019
-
Mark
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5) : a 2-year interim analysis of a multicentre, prospective, cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care : Multicenter external validation using decision curve analysis
(
- Contribution to journal › Article
- 2016
-
Mark
Age-related differences in the sonographic characteristics of endometriomas
(
- Contribution to journal › Article
-
Mark
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis (IOTA) group.
(
- Contribution to journal › Article
- 2014
-
Mark
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
(
- Contribution to journal › Article